日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Attenuating hypoxia driven malignant behavior in glioblastoma with a novel hypoxia-inducible factor 2 alpha inhibitor

使用新型缺氧诱导因子 2 α 抑制剂减轻胶质母细胞瘤缺氧驱动的恶性行为

Jaclyn J Renfrow, Michael H Soike, James L West, Shakti H Ramkissoon, Linda Metheny-Barlow, Ryan T Mott, Carol A Kittel, Ralph B D'Agostino Jr, Stephen B Tatter, Adrian W Laxton, Mark B Frenkel, Gregory A Hawkins, Denise Herpai, Stephanie Sanders, Jann N Sarkaria, Glenn J Lesser, Waldemar Debinski, 

Efficacy of osimertinib against EGFRvIII+ glioblastoma

奥希替尼对 EGFRvIII+ 胶质母细胞瘤的疗效

Gustavo Chagoya #, Shawn G Kwatra #, Cory W Nanni, Callie M Roberts, Samantha M Phillips, Sarah Nullmeyergh, Samuel P Gilmore, Ivan Spasojevic, David L Corcoran, Christopher C Young, Karla V Ballman, Rohan Ramakrishna, Darren A Cross, James M Markert, Michael Lim, Mark R Gilbert, Glenn J Lesser, Mad

Phase II study of monthly pasireotide LAR (SOM230C) for recurrent or progressive meningioma

每月一次帕瑞肽 LAR(SOM230C)治疗复发性或进行性脑膜瘤的 II 期研究

Andrew D Norden, Keith L Ligon, Samantha N Hammond, Alona Muzikansky, David A Reardon, Thomas J Kaley, Tracy T Batchelor, Scott R Plotkin, Jeffrey J Raizer, Eric T Wong, Jan Drappatz, Glenn J Lesser, Sam Haidar, Rameen Beroukhim, Eudocia Q Lee, Lisa Doherty, Debra Lafrankie, Sarah C Gaffey, Mary Ger

A randomized, double-blind, placebo-controlled study of oral coenzyme Q10 to relieve self-reported treatment-related fatigue in newly diagnosed patients with breast cancer

一项随机、双盲、安慰剂对照研究,探讨口服辅酶 Q10 对缓解新诊断乳腺癌患者自述治疗相关疲劳的效果

Glenn J Lesser, Doug Case, Nancy Stark, Susan Williford, Jeff Giguere, L Astrid Garino, Michelle J Naughton, Mara Z Vitolins, Mark O Lively, Edward G Shaw; Wake Forest University Community Clinical Oncology Program Research Base